Wednesday, January 20
    Home>> Business>>Bristol-Myers gets ‘potentially revolutionary medicine’ in MyoKardia deal, CEO says
    Business

    Bristol-Myers gets ‘potentially revolutionary medicine’ in MyoKardia deal, CEO says

    AdminOctober 6, 2020 42 Views0
    Related tags : Bristol-Myers Squibb CoGiovanni CaforioMyoKardia IncPharmaceuticals

    Related Articles

    Business

    UK’s Boris Johnson outlines three-tier system of local lockdowns, dividing the country with stricter measures

    Business

    How Jio Prepaid Users Can Migrate To Postpaid Plus

    Business

    Electric-vehicle SPAC sell-off is a ‘sign of health,’ Jim Cramer says

    Business

    FDA authorizes Regeneron’s Covid treatment, taken by Trump, for emergency use

    Business

    Huge layoffs expected in wake of second lockdown in Canada

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: